Introduction

I
n the third stage of the USP Dissolution Test with pooled samples (1) ,(criteria shown in Table 1 ),the average value of the lot submitted to inspection is compared with the value of the parameter Q specified in the monograph. When the third stage is reached,the calculation of the average of the 3 values obtained in the three stages,can originate the question if the value of the third stage must be weighted double taking in account the fact that they are twelve units instead of six. The following aspects are investigated in this paper: a. Which is the best estimate of the mean value (weighted vs. non-weighted estimations), b. Which are the consequences of applying an expression that differs from the optimum for estimation of the mean, c. Which would be the consequences of taking a sample of only six units also in the third stage instead of twelve.
Discussion
To perform this work a statistical model of the inspection has been built,including the following sources of variability in the results of each stage:
• Product variability: variability between units of the product refers to the dissolved amount in the dissolution test (i.e. variability of the concentration of analyte present in the vessel at the end of the dissolution test). This component was described using the RSD (relative standard deviation). A RSD range of 1-10% covering the usual values (2) was studied.
• Variability (or uncertainty) due to measurements, including:
• Variability of aliquot volumes used to make the pooled sample. This variability has been modeled using CVp (coefficient of variation of volume delivered); its usual value was considered to be 0.01 (1%).
• Variability related to the operation of adjusting pooled volume. This variability has been modeled using CVe (coefficient of variation of the filling of the volumetric flask); its usual value was considered to be 0.005 (0.5%).
• Variability related to the measurement of the concentration of the analyte in the pooled solution. This has been modeled using CVa (coefficient of variation of analysis); figures taken were between 0.005 and 0.03 (0.5-3%) in order to consider the different analytical procedures that might be used.
Performing the usual approximation, where:
any and any , variability of results of each stage is obtained:
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With the results of stages 1, 2 and 3, the mean value of the lot is estimated (m) and the decision of acceptance or rejection is taken by comparing this value with Q.
The method established by USP gives equal weights to the three results despite the fact that they have been obtained with different numbers of dosage units.
In a general way, weighting of the results can be expressed as follows: (3) In this equation the following considerations have been assumed:
• Same weighting is given to results 1 and 2 because they have similar variability, • Result for stage 3 is weighted by a factor (1-2w), which assures that the three factors add to 1 and m is an average of the results obtained.
The variability of the calculated mean value (m) is given by:
The partial derivative of equation 4 with respect to w is:
Then it can be obtained the value of w, which makes minimum the variability of the calculated average value m, and therefore the most efficient estimator of the mean (3). The expression is as follows: (6) A value of w = 1/3, indicates that the best estimation is obtained giving to the three results the same weighting, while a value of w = 1/4 indicates that in order to obtain minimum variability in m (estimation of mean lot value), double weighting must be given to the stage 3 result.
In order to quantify the results, w has been studied as a function of the analytical parameters and the variability of the lot expressed as RSD. Data are shown in Table 2 .
Values obtained show that: • There is not a unique optimum value of w in the range of parameters considered, • When the variability of m is dominated by measurement (low RSD, high CVa) the optimum w value approaches 1/3, but when product variability dominates (high RSD, low CVa), optimum value of w approaches 1/4. If measurement variability were negligible, optimum value of w will be 1/4, which means double weighting for the stage 3 value.
To assess the loss of efficiency caused by using a fixed value of w, lot average variabilities obtained with an optimum value of w were compared with those obtained using values of 1/3 and 1/4 (data are shown in Table 3 ).
From the analysis of the table it is shown that:
• Variability of measurements is key to determining which weighting is more convenient. A more detailed analysis is shown in Figures 1and 2. • The loss of efficiency when w = 1/3 is used (compared with the optimum w value) is not significant; in the worst case, variability increases 4.8%. Below the x-axis, w = 1/4 is preferred. Figure 2 shows preferred zones as a function of RSD and CVa. In the zone above (below) the curve w = 1/4 (w = 1/3) is preferred. This curve was obtained equating variability calculated with w = 1/3 and w = 1/4. Points on the curve have the same variability.
It can be seen in Table 3 that total variability coefficient is a function of RSD and CVa.
Due to the analysis variability contribution, an increase in sample size (6 to 12) reduces variability of the stage 3 average less than could be expected if analysis variability contribution didn't exist.
In order to evaluate the improvement due to additional samples, Table 4 has been prepared. In these calculations, the same values of CVe and CVp were used and a weighting factor of w = 1/3 was applied.
The reduction of variability due to additional samples is less than 9,1% in all the ranges of parameters studied.
Verification
In order to verify the theoretical analysis, simulations were performed taking into account the statistical model outlined.
Each value shown in Table 5 is the average of 1000 repetitions and the resultant confidence interval (95%) is approximately 0.06.
The results of the simulation are in agreement with calculations within the confidence intervals. The maximum observed difference (a = 1/4, RSD = 2 and Cva = 0.005) is 5.9%.
Conclusions
The optimum weighting factor is variable. Depending on the relative values of the sources of variability, equal weighting (as established by USP 27) or double weighting third stage, provides estimators of lot mean with less variability. In any case, loss of efficiency (increase in variability) due to the use of a fixed, equal weighting to calculate average is not significant. Third stage testing could be reduced to six units without introducing a noticeable increase of risks in the acceptance/rejection decisions since there is little increase in the variability of the estimated average.
